JSPRW (STOCKS)
Japer Therapeutics, Inc. Warrants
$0.019900
+0.001800 (+9.94%)
Prev close: $0.018100
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jeet Mahal, MBA
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 64
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $2.31M |
| Operating Expenses | $93.33M |
| Depreciation and Amortization | $1.01M |
| Research and Development | $71.52M |
| Other Operating Expenses | $20.80M |
| Operating Income/Loss | -$93.33M |
| Income/Loss From Continuing Operations After Tax | -$91.02M |
| Income/Loss From Continuing Operations Before Tax | -$91.02M |
| Net Income/Loss | -$91.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$91.02M |
| Net Income/Loss Available To Common Stockholders, Basic | -$91.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.82 |
| Diluted Earnings Per Share | -$5.82 |
| Basic Average Shares | 16,110,436 |
| Diluted Average Shares | 16,110,436 |
| Assets | $57.47M |
| Current Assets | $54.56M |
| Noncurrent Assets | $2.91M |
| Fixed Assets | $1.10M |
| Other Non-current Assets | $1.80M |
| Liabilities | $45.90M |
| Current Liabilities | $21.04M |
| Accounts Payable | $9.17M |
| Wages | $1.66M |
| Other Current Liabilities | $10.22M |
| Noncurrent Liabilities | $24.86M |
| Equity | $11.57M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.57M |
| Liabilities And Equity | $57.47M |
| Net Cash Flow From Operating Activities | -$76.43M |
| Net Cash Flow From Operating Activities, Continuing | -$76.43M |
| Net Cash Flow From Investing Activities | -$71.00K |
| Net Cash Flow From Investing Activities, Continuing | -$71.00K |
| Net Cash Flow From Financing Activities | $34.90M |
| Net Cash Flow From Financing Activities, Continuing | $34.90M |
| Net Cash Flow | -$41.60M |
| Net Cash Flow, Continuing | -$41.60M |
| Comprehensive Income/Loss | -$91.02M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$91.02M |
| Other Comprehensive Income/Loss | $0.00 |